Uihlein Richard E
SEC insider (Form 3/4/5 filer). CIK 0001694903. Director & 10% Owner at GALECTIN THERAPEUTICS INC (GALT). 4 reported Form 4/5 transactions since Sep 2024; latest on Jul 31, 2026. Located in NORCROSS, GA.
Companies Uihlein Richard E has filed insider reports for
- GALECTIN THERAPEUTICS INC (GALT): Director, 10% Owner
Uihlein Richard E
CIK: 0001694903
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)2 (50.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GALT
GALECTIN THERAPEUTICS INC
Director10% Owner
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 31, 2026GALT
GALECTIN THERAPEUTICS INC
ExerciseIndirect31.8M shares at avg. $3.00$95.5M - Jul 31, 2026GALT
GALECTIN THERAPEUTICS INC
ExerciseIndirect2.6M shares at avg. $4.05$10.3M - Jan 16, 2026GALT
GALECTIN THERAPEUTICS INC
AwardDirect13.2K shares at avg. $3.04$40K - Jan 23, 2025GALT
GALECTIN THERAPEUTICS INC
AwardDirect32.5K shares at avg. $1.23$40K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 31, 2026 | GALT GALECTIN THERAPEUTICS INC | Exercise | 31,825,235 | $3.00 | $95,475,705 | Indirect |
| Jul 31, 2026 | GALT GALECTIN THERAPEUTICS INC | Exercise | 2,550,932 | $4.05 | $10,331,275 | Indirect |
| Jan 16, 2026 | GALT GALECTIN THERAPEUTICS INC | Award | 13,158 | $3.04 | $40,000 | Direct |
| Jan 23, 2025 | GALT GALECTIN THERAPEUTICS INC | Award | 32,520 | $1.23 | $40,000 | Direct |
1-4 of 4 transactions